HealthEquity (HQY)
(Delayed Data from NSDQ)
$79.20 USD
-0.67 (-0.84%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $79.24 +0.04 (0.05%) 7:50 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Income Statements
Fiscal Year end for HealthEquity, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 1,000 | 862 | 757 | 734 | 532 |
Cost Of Goods | 377 | 372 | 333 | 318 | 206 |
Gross Profit | 623 | 490 | 424 | 415 | 326 |
Selling & Adminstrative & Depr. & Amort Expenses | 505 | 481 | 448 | 381 | 249 |
Income After Depreciation & Amortization | 118 | 9 | -24 | 34 | 77 |
Non-Operating Income | 13 | 1 | -6 | 5 | -9 |
Interest Expense | 55 | 48 | 37 | 35 | 25 |
Pretax Income | 75 | -38 | -67 | 4 | 43 |
Income Taxes | 19 | -12 | -22 | -5 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 56 | -26 | -44 | 9 | 40 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 56 | -26 | -44 | 9 | 40 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 274 | 174 | 117 | 155 | 132 |
Depreciation & Amortization (Cash Flow) | 156 | 164 | 142 | 121 | 55 |
Income After Depreciation & Amortization | 118 | 9 | -24 | 34 | 77 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 86.96 | 84.44 | 83.13 | 75.68 | 68.45 |
Diluted EPS Before Non-Recurring Items | 1.58 | 0.77 | 0.82 | 1.22 | 1.38 |
Diluted Net EPS (GAAP) | 0.64 | -0.31 | -0.53 | 0.12 | 0.58 |
Fiscal Year end for HealthEquity, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 262.39 | 249.22 | 243.55 | 244.43 | 233.84 |
Cost Of Goods | 96.91 | 90.81 | 92.62 | 96.61 | 99.59 |
Gross Profit | 165.47 | 158.41 | 150.93 | 147.83 | 134.25 |
SG&A, R&D, and Dept/Amort Expenses | 126.59 | 127.51 | 126.20 | 124.65 | 121.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 38.88 | 30.90 | 24.73 | 23.18 | 13.22 |
Non-Operating Income | 4.47 | 3.74 | 2.76 | 1.83 | 1.10 |
Interest Expense | 13.64 | 13.55 | 13.27 | 15.00 | 14.31 |
Pretax Income | 29.72 | 21.09 | 14.22 | 10.01 | 0.01 |
Income Taxes | 3.35 | 6.41 | 3.64 | 5.92 | 0.22 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 26.36 | 14.67 | 10.58 | 4.09 | -0.21 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 26.36 | 14.67 | 10.58 | 4.09 | -0.21 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 87.44 | 87.12 | 86.34 | 86.10 | 84.72 |
Diluted EPS Before Non-Recurring Items | 0.50 | 0.40 | 0.34 | 0.32 | 0.26 |
Diluted Net EPS (GAAP) | 0.30 | 0.17 | 0.12 | 0.05 | 0.00 |